FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

PHASE4CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Hypertension
Interventions
DRUG

Nifedipine (Adalat, BAYA1040) and Valsartan

Combination treatment with nifedipine GITS 30mg and valsartan 80mg, Once daily

DRUG

Nifedipine (Adalat, BAYA1040)

Nifedipine 60mg, Once daily

DRUG

Valsartan

Valsartan 160mg, Once daily

Trial Locations (15)

410-773

Goyang

411-706

Goyang-si

361-711

Chungchungbuk-do

135-720

Seoul

152-703

Seoul

Unknown

Busan

501-757

Gwangju

100-380

Joong-gu

463-707

Kungki-do

110-744

Seoul

120-752

Seoul

135-710

Seoul

136-705

Seoul

137-701

Seoul

443-721

Suwan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY